Billiontoone (NASDAQ:BLLN) Stock Price Up 6.2% – What’s Next?

Billiontoone, Inc. (NASDAQ:BLLN) shares rose 6.2% during mid-day trading on Monday . The company traded as high as $85.76 and last traded at $84.2960. Approximately 90,486 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 276,484 shares. The stock had previously closed at $79.36.

Analyst Upgrades and Downgrades

BLLN has been the subject of several research analyst reports. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. JPMorgan Chase & Co. lowered their price objective on Billiontoone from $150.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, December 10th. Guggenheim cut their price objective on Billiontoone from $120.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, March 30th. Piper Sandler reiterated an “overweight” rating on shares of Billiontoone in a research report on Wednesday, December 10th. Finally, BTIG Research dropped their price target on Billiontoone from $160.00 to $140.00 and set a “buy” rating on the stock in a research report on Thursday, March 5th. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $126.71.

Billiontoone Trading Up 4.8%

The company has a market cap of $3.82 billion and a price-to-earnings ratio of 394.41. The company has a quick ratio of 11.32, a current ratio of 11.69 and a debt-to-equity ratio of 0.12. The company has a 50-day moving average of $79.18.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, March 4th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.07. The company had revenue of $96.05 million during the quarter, compared to the consensus estimate of $85.85 million. The company’s revenue for the quarter was up 113.0% compared to the same quarter last year.

Institutional Investors Weigh In On Billiontoone

Several institutional investors have recently bought and sold shares of BLLN. Rossby Financial LCC acquired a new position in Billiontoone during the 4th quarter valued at about $25,000. Wells Fargo & Company MN bought a new position in shares of Billiontoone in the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC bought a new stake in Billiontoone during the fourth quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in Billiontoone in the fourth quarter worth approximately $82,000. Finally, Renaissance Capital LLC acquired a new position in shares of Billiontoone during the 4th quarter valued at $201,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.